• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Global Equity

Chinese Stocks Surge in Hong Kong With Hints of Reopening

Investors continue to buy on tiny signs that China is easing up on its zero-Covid stance, but newly relaxed rules have yet to be put to the test.
By ALEX FREW MCMILLAN
Dec 05, 2022 | 07:12 AM EST
Stocks quotes in this article: MS, BILI, XPEV, NIO, LI, XIACY, BIDU, JD, BABA, TCTZF, NTES, SCHYY, GS

Chinese shares are surging on Monday as a dozen or so major cities adjust their anti-Covid rules to make them easier to follow.

The market is also buoyed by positive sentiment from houses such as Morgan Stanley (MS) , which on Sunday raised its call on Chinese equities to "overweight". It had held an "equal weight" rating since January 2021.

The Hang Seng Tech Index shot 9.3% higher by Monday's close, gaining momentum throughout the trading day. There were massive gains for companies such as the online health clinic and pharmacy Ping An Good Doctor HK:1833 (up 37.9%), the short-video service Bilibili HK:9626 and (BILI) (up 28.8%) and the electric-car manufacturer XPeng HK:9868 and (XPEV) (up 26.4%).

Those were the top three showings in the tech index. The other U.S.-listed EV makers, Nio HK:9866 and (NIO) (up 14.9%) and Li Auto HK:2015 and (LI) (up 12.2%) also notched impressive gains. They would be prime beneficiaries of any recovery in China's battered consumer sentiment. The rival online health clinic Ali Health HK:0241, up 19.9%, also notched an eye-watering advance.

The Hang Seng China Enterprises Index also moved sharply higher in Hong Kong, up 5.3% at the close, with the broader Hang Seng Index up 4.5%. Megacaps such as cellphone maker Xiaomi HK:1810 and (XIACY) (up 13.6%), browser and cloud-computing operator Baidu HK:9888 and (BIDU) (up 11.1%), and e-commerce platforms JD.com HK:9618 and (JD) (up 11.2%) and rival Alibaba Group Holding HK:9988 and (BABA) (up 9.3%) also saw an impressive performance.

Overseas investors will do most of their buying of Chinese shares in Hong Kong, where many U.S.-listed companies now also have a listing. Access to the Shanghai and Shenzhen markets is tightly controlled for foreign investors, and there are also caps on how far a stock can move in one day. The CSI 300 of the largest mainland companies closed 2.0% higher on Monday.

In Hong Kong, the operator of the WeChat superapp, Tencent Holdings HK:0700 and (TCTZF) finished up 6.1%, with U.S.-listed videogame maker NetEase HK:9999 and (NTES) up 5.8.%. It is a sign of how sharp Monday's gains have been that those advances seem prosaic by comparison.

Make no mistake. China has not suddenly scrapped its zero-Covid stance. But a dozen major cities have loosened rules over the weekend, with what the state-run Global Times calls "adjusted and optimized epidemic control measures."

Shanghai, China's largest city, said on Sunday that as of today it no longer requires people to show a negative result from a nucleic-acid test to ride public transportation, as well as to enter some outdoor venues.

Shenzhen, China's tech hub at the heart of Guangdong, China's most-productive province, said over the weekend that residents will no longer need evidence of a negative Covid test to take public transport, visit parks or enter outdoor tourist attractions. But it said citizens will still have to show a green health code and record entry to the venue as they enter airports and train stations.

Nearby Zhuhai, just across the border from Macau, has stopped providing free nucleic-acid testing and will now charge ¥2.6 (US$0.37) per person. Both Zhuhai and the central megacity of Chongqing are urging residents not to take Covid tests unless absolutely necessary. Casino operator Sands China HK:1928 and (SCHYY) is a classic "reopening stock," and ended Monday up 13.8% in Hong Kong.

The megacities of Guangzhou and Beijing have begun allowing some close contacts of Covid cases as well as some asymptomatic carriers to serve out their quarantine time at home. That's a major shift away from the previous policy, which forced every Covid case and many close contacts into a highly unpopular quarantine at a stark centralized facility.

I'm skeptical that this really is an end to zero-Covid. You'll see by those city-by-city stipulations that a) there are still a lot of Covid rules in China, b) it's hard to keep track of what you're allowed to do, when and where, and c) anti-Covid rules will still therefore play a dominant role in everyday life. This is the 9th edition of China's Covid protocols, with 20 "optimized measures for combating the virus."

The changes over the weekend do make life easier in many big cities. But it's equally possible that the Chinese authorities will roll out a 10th, 11th and 12th edition with dozens more "optimized" and "adjusted" measures and protocols that restrict access again should Covid infections rise substantially.

One major change in tune for the Chinese authorities is that they have started to state that Covid shows "weakened pathogenicity," contradicting earlier statements made to justify the zero-Covid policy. This admission that Covid is weaker than it once was could be the first step in providing the basis for a move away from zero-Covid to living with the virus.

Having hit a high of 43,026 on December 1, new Covid infections across China have dipped slightly again, to 36,196 as of Sunday. Health authorities will take encouragement that what had been a precipitous rise appears to have turned around. Should we see a sudden leap again, though, all bets will be off on opening up.

The infection numbers are tiny considering China's 1.4 billion population. But the fear is that the healthcare system would be overrun by a large-scale nationwide outbreak, creating similar conditions to those experienced in Western Europe in the early stages of the outbreak in 2020. What's more, Chinese vaccines showed a weaker performance against early strains of Covid than their overseas counterparts, and it's unknown in terms of peer-reviewed research how much protection they offer against the latest strains.

The Chinese Communist Party has been shaken by the demonstrations two weekends back against the zero-Covid policy. There were no signs over this weekend of a resurgence, as Chinese authorities surveil potential protest sites and attempt to track down those who participated, to stamp out dissent. The CCP rules largely on the premise that it will ensure stability and solid economic growth so long as the public give up on pursuing politics and democracy.

The dire state of China's economy, forecast to slow to 3.2% growth for 2022 and miss the official target of around 5.5%, and the party's intrusion into daily life has united Chinese citizens from many walks of life in a shared grievance against the zero-Covid stance.

The Chinese yuan also strengthened on Monday, breaking through the C¥7.00 barrier to the U.S. dollar, and now stands at C¥6.96 to the greenback. In the last month, it has firmed to the tune of 4.7%, from peak weakness of C¥7.31 to the U.S. dollar.

There's also been positive noise on the China market from Goldman Sachs (GS) , which says Chinese equities should outperform in 2023. Ajay Kapur, the chief Asia Pacific equity strategist at Bank of America Securities, said last month he has turned "tactically positive" on China after two years of caution.

Investors buying into the China stocks rally now are certainly buying into hints of opening up across China, rather than a full relaxation of zero-Covid. It'll take time to see if those easier Covid rules still stand should Covid infections escalate.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Alex Frew McMillan had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading | China | Global Equity | Coronavirus

More from Global Equity

Adani Shares Stabilize on Earnings, Early Debt Payment

Alex Frew McMillan
Feb 8, 2023 7:04 AM EST

Flagship Adani Enterprises saw its shares climb 23.1% today, while other group companies generally advanced.

Adani Implosion Threatens Broader Blow to Indian Markets

Alex Frew McMillan
Feb 3, 2023 8:54 AM EST

Indian opposition politicians are demanding an investigation into the government's ties with the Adani Group, as Boris Johnson's brother steps down from linked investment bank.

Alibaba Gaps Lower in U.S. Trading: Here's Why and What's Next

Bruce Kamich
Jan 30, 2023 11:12 AM EST

A stock that rises on shrinking volume is suspect.

Adani Delivers Tome in Response to Short-Sale 'Attack on India'

Alex Frew McMillan
Jan 30, 2023 6:35 AM EST

As the founder slips down the rich list, the Adani Group says Hindenburg Research report is an attack on the very nation of India.

Adani Companies Plunge Under Hindenburg Attack, Hurting Secondary Sale Attempt

Alex Frew McMillan
Jan 27, 2023 9:30 AM EST

Retail investors may baulk now they are being offered Adani Enterprises shares at a range well above their current trading price.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:20 AM EST PETER TCHIR

    Powell, 0DTE Options and How I View This Market Right Now

    Fed Chair Powell is saying all the things I think ...
  • 08:22 AM EST REAL MONEY

    LIVE EVENT: Bruce Kamich and Todd Campbell Share Their Stock Market Insights

    This Monday, Feb. 6 at 12 p.m., our very own exper...
  • 02:58 PM EST REAL MONEY

    Sarge Guilfoyle Breaks Down the Jobs Report, Fed Policy and Stocks!

    Watch it here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login